You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neoplasms, Squamous Cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Squamous Cell Cancer, Squamous Cell Carcinoma, Skin Cancer Trial in Boise (30% ascorbic acid in DMSO)

Recruiting
  • Squamous Cell Cancer
  • +3 more
  • 30% ascorbic acid in DMSO
  • Boise, Idaho
    Center for Biomedical Research,Inc.
Jul 2, 2023

Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to

Active, not recruiting
  • Esophageal Cancer
  • follow up
  • Guangzhou, Guangdong, China
    Jianhua Fu
Sep 24, 2023

Vulva Cancer, Vulva Tumor, Squamous Cell Cancer Trial (Pembrolizumab)

Not yet recruiting
  • Vulva Cancer
  • +2 more
  • (no location specified)
Mar 7, 2023

Esophageal Squamous Cell Cancer Trial in Beijing (Toripalimab, Paclitaxel, Cisplatin)

Recruiting
  • Esophageal Squamous Cell Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital / Peking University Cancer Hospital
Jan 30, 2023

Esophageal Squamous Cell Carcinomas, Concurrent Chemoradiotherapy, Immunotherapy Trial (chemo combined with PD-1 inhibitors)

Not yet recruiting
  • Esophageal Squamous Cell Carcinomas
  • +3 more
  • chemotherapy combined with PD-1 inhibitors
  • (no location specified)
Nov 17, 2022

Primary Tumor Burden Score:A Novel Staging Parameter for ESCC

Completed
  • Neoplasm, Esophagus
  • Neoplasm, Squamous Cell
  • nCRT
  • (no location specified)
Apr 20, 2023

Head and Neck Squamous Cell Cancer

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • OncoPrism-HNSCC™
  • San Francisco, California
    Curebase
Sep 7, 2022

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Penpulimab Combined With CRT)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Penpulimab Combined With CRT
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Sep 28, 2022

Squamous Cell Cancers of the Head and Neck Trial in New Haven (cetuximab, afatinib)

Recruiting
  • Squamous Cell Cancers of the Head and Neck
  • New Haven, Connecticut
    Yale Cancer Center
Jan 10, 2023

Head and Neck Squamous Cell Cancer Trial in Shanghai (Toripalimab Injection, Cetuximab Solution for infusion)

Recruiting
  • Head and Neck Squamous Cell Cancer
  • Toripalimab Injection
  • Cetuximab Solution for infusion
  • Shanghai, China
    Shanghai East Hospital
Dec 15, 2022

Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity

Active, not recruiting
Has Results
  • Squamous Cell Carcinoma of the Oropharynx
  • +7 more
  • Tampa, Florida
  • +2 more
Dec 30, 2022

Head and Neck Squamous Cell Cancer Trial (pembrolizumab, methotrexate, docetaxel)

Completed
Has Results
  • Head and Neck Squamous Cell Cancer
  • pembrolizumab
  • +3 more
  • (no location specified)
Aug 24, 2022

Recurrent Head and Neck Squamous Cell Carcinoma Trial in Atlanta, Cleveland, Milwaukee (IMRT, Nivolumab)

Active, not recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • IMRT
  • Nivolumab
  • Atlanta, Georgia
  • +3 more
Jan 10, 2023

Respiratory Tract Diseases, Tumors, Tumors by Histologic Type Trial run by the National Cancer Institute (NCI) (Bevacizumab)

Not yet recruiting
  • Respiratory Tract Diseases
  • +14 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 10, 2023

Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma Trial in Guangzhou

Recruiting
  • Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma
  • Tucidinostat (chidamide) and PD-1 inhibitor （Toripalimab）
  • Guangzhou, Guangdong, China
    Cancer center of Sun Yat-sen University
Jul 20, 2022

Esophageal Squamous Cell Carcinoma, Esophageal Tumors, Esophageal Diseases Trial (Anlotinib HCl, TQB2450)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • +10 more
  • (no location specified)
Feb 19, 2022

Advanced Solid Tumor, NSCLC, Small Cell Lung Cancer Trial (IMM2520)

Not yet recruiting
  • Advanced Solid Tumor
  • +5 more
  • (no location specified)
Mar 20, 2023

Squamous Cell Carcinoma of the Head and Neck Trial in Cleveland (Pembrolizumab, IMRT 60-66Gy)

Completed
Has Results
  • Squamous Cell Carcinoma of the Head and Neck
  • Cleveland, Ohio
  • +1 more
Jun 29, 2022

Head and Neck Squamous Cell Cancer Trial in London (BYL719)

Active, not recruiting
  • Head and Neck Squamous Cell Cancer
  • London, Ontario, Canada
    London Health Sciences Centre, London Regional Cancer Program
Jun 14, 2022

Stage T3 Squamous Cell Carcinomas of the Scalp

Active, not recruiting
  • Squamous Cell Carcinoma
  • +2 more
    • Maastricht, Netherlands
      Ellen Oyen
    Aug 3, 2023

    Advanced Esophageal Squamous Cell Cancer Trial in Jinan (Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy)

    Recruiting
    • Advanced Esophageal Squamous Cell Cancer
    • Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy
    • Jinan, Shandong, China
      Shandong Cancer Hospital and Institute
    Apr 11, 2022

    Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell

    Withdrawn
    • Multiple Indications Cancer
    • Non-Interventional
    • Mexico, Distrito Federal, Mexico
      Local Institution
    May 25, 2022

    Oral Cancer, Oral Squamous Cell Carcinoma Trial in Fayoum (ELISA)

    Recruiting
    • Oral Cancer
    • Oral Squamous Cell Carcinoma
    • ELISA
    • Fayoum, Egypt
      Fayoum University
    Sep 8, 2023

    Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])

    Not yet recruiting
    • Neoplasms
    • +2 more
    • Nivolumab Injection [Opdivo]
    • (no location specified)
    Jul 19, 2023

    Stage IV Esophagus Squamous Cell Carcinoma Trial in Hangzhou (Camrelizumab, Irinotecan, Paclitaxel)

    Not yet recruiting
    • Stage IV Esophagus Squamous Cell Carcinoma
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Apr 2, 2022